Global Personalized Medicine (PM) Solution Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Personalized Medicine (PM) Solution Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Personalized Diagnostics
  • 1.2.3 Personalized Therapies
  • 1.2.4 Personalized Nutrition & Wellness
• 1.3 Market by Application
  • 1.3.1 Global Personalized Medicine (PM) Solution Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Oncology
  • 1.3.3 Neurosciences
  • 1.3.4 Immunology
  • 1.3.5 Respiratory
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Personalized Medicine (PM) Solution Market Perspective (2016-2027)
• 2.2 Personalized Medicine (PM) Solution Growth Trends by Regions
  • 2.2.1 Personalized Medicine (PM) Solution Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Personalized Medicine (PM) Solution Historic Market Share by Regions (2016-2021)
  • 2.2.3 Personalized Medicine (PM) Solution Forecasted Market Size by Regions (2022-2027)
• 2.3 Personalized Medicine (PM) Solution Industry Dynamic
  • 2.3.1 Personalized Medicine (PM) Solution Market Trends
  • 2.3.2 Personalized Medicine (PM) Solution Market Drivers
  • 2.3.3 Personalized Medicine (PM) Solution Market Challenges
  • 2.3.4 Personalized Medicine (PM) Solution Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Personalized Medicine (PM) Solution Players by Revenue
  • 3.1.1 Global Top Personalized Medicine (PM) Solution Players by Revenue (2016-2021)
  • 3.1.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Players (2016-2021)
• 3.2 Global Personalized Medicine (PM) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Personalized Medicine (PM) Solution Revenue
• 3.4 Global Personalized Medicine (PM) Solution Market Concentration Ratio
  • 3.4.1 Global Personalized Medicine (PM) Solution Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine (PM) Solution Revenue in 2020
• 3.5 Personalized Medicine (PM) Solution Key Players Head office and Area Served
• 3.6 Key Players Personalized Medicine (PM) Solution Product Solution and Service
• 3.7 Date of Enter into Personalized Medicine (PM) Solution Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Medicine (PM) Solution Breakdown Data by Type

• 4.1 Global Personalized Medicine (PM) Solution Historic Market Size by Type (2016-2021)
• 4.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Type (2022-2027)

5 Personalized Medicine (PM) Solution Breakdown Data by Application

• 5.1 Global Personalized Medicine (PM) Solution Historic Market Size by Application (2016-2021)
• 5.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Personalized Medicine (PM) Solution Market Size (2016-2027)
• 6.2 North America Personalized Medicine (PM) Solution Market Size by Type
  • 6.2.1 North America Personalized Medicine (PM) Solution Market Size by Type (2016-2021)
  • 6.2.2 North America Personalized Medicine (PM) Solution Market Size by Type (2022-2027)
  • 6.2.3 North America Personalized Medicine (PM) Solution Market Size by Type (2016-2027)
• 6.3 North America Personalized Medicine (PM) Solution Market Size by Application
  • 6.3.1 North America Personalized Medicine (PM) Solution Market Size by Application (2016-2021)
  • 6.3.2 North America Personalized Medicine (PM) Solution Market Size by Application (2022-2027)
  • 6.3.3 North America Personalized Medicine (PM) Solution Market Size by Application (2016-2027)
• 6.4 North America Personalized Medicine (PM) Solution Market Size by Country
  • 6.4.1 North America Personalized Medicine (PM) Solution Market Size by Country (2016-2021)
  • 6.4.2 North America Personalized Medicine (PM) Solution Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Personalized Medicine (PM) Solution Market Size (2016-2027)
• 7.2 Europe Personalized Medicine (PM) Solution Market Size by Type
  • 7.2.1 Europe Personalized Medicine (PM) Solution Market Size by Type (2016-2021)
  • 7.2.2 Europe Personalized Medicine (PM) Solution Market Size by Type (2022-2027)
  • 7.2.3 Europe Personalized Medicine (PM) Solution Market Size by Type (2016-2027)
• 7.3 Europe Personalized Medicine (PM) Solution Market Size by Application
  • 7.3.1 Europe Personalized Medicine (PM) Solution Market Size by Application (2016-2021)
  • 7.3.2 Europe Personalized Medicine (PM) Solution Market Size by Application (2022-2027)
  • 7.3.3 Europe Personalized Medicine (PM) Solution Market Size by Application (2016-2027)
• 7.4 Europe Personalized Medicine (PM) Solution Market Size by Country
  • 7.4.1 Europe Personalized Medicine (PM) Solution Market Size by Country (2016-2021)
  • 7.4.2 Europe Personalized Medicine (PM) Solution Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size (2016-2027)
• 8.2 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Type
  • 8.2.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Application
  • 8.3.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region
  • 8.4.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Personalized Medicine (PM) Solution Market Size (2016-2027)
• 9.2 Latin America Personalized Medicine (PM) Solution Market Size by Type
  • 9.2.1 Latin America Personalized Medicine (PM) Solution Market Size by Type (2016-2021)
  • 9.2.2 Latin America Personalized Medicine (PM) Solution Market Size by Type (2022-2027)
  • 9.2.3 Latin America Personalized Medicine (PM) Solution Market Size by Type (2016-2027)
• 9.3 Latin America Personalized Medicine (PM) Solution Market Size by Application
  • 9.3.1 Latin America Personalized Medicine (PM) Solution Market Size by Application (2016-2021)
  • 9.3.2 Latin America Personalized Medicine (PM) Solution Market Size by Application (2022-2027)
  • 9.3.3 Latin America Personalized Medicine (PM) Solution Market Size by Application (2016-2027)
• 9.4 Latin America Personalized Medicine (PM) Solution Market Size by Country
  • 9.4.1 Latin America Personalized Medicine (PM) Solution Market Size by Country (2016-2021)
  • 9.4.2 Latin America Personalized Medicine (PM) Solution Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size (2016-2027)
• 10.2 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Type
  • 10.2.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Application
  • 10.3.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country
  • 10.4.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 2bPrecise
  • 11.1.1 2bPrecise Company Details
  • 11.1.2 2bPrecise Business Overview
  • 11.1.3 2bPrecise Personalized Medicine (PM) Solution Introduction
  • 11.1.4 2bPrecise Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.1.5 2bPrecise Recent Development
• 11.2 OneOme
  • 11.2.1 OneOme Company Details
  • 11.2.2 OneOme Business Overview
  • 11.2.3 OneOme Personalized Medicine (PM) Solution Introduction
  • 11.2.4 OneOme Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.2.5 OneOme Recent Development
• 11.3 TIGAR Health- IR2Dx
  • 11.3.1 TIGAR Health- IR2Dx Company Details
  • 11.3.2 TIGAR Health- IR2Dx Business Overview
  • 11.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Introduction
  • 11.3.4 TIGAR Health- IR2Dx Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.3.5 TIGAR Health- IR2Dx Recent Development
• 11.4 Kailos Genetics
  • 11.4.1 Kailos Genetics Company Details
  • 11.4.2 Kailos Genetics Business Overview
  • 11.4.3 Kailos Genetics Personalized Medicine (PM) Solution Introduction
  • 11.4.4 Kailos Genetics Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.4.5 Kailos Genetics Recent Development
• 11.5 Syapse Inc
  • 11.5.1 Syapse Inc Company Details
  • 11.5.2 Syapse Inc Business Overview
  • 11.5.3 Syapse Inc Personalized Medicine (PM) Solution Introduction
  • 11.5.4 Syapse Inc Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.5.5 Syapse Inc Recent Development
• 11.6 Karius
  • 11.6.1 Karius Company Details
  • 11.6.2 Karius Business Overview
  • 11.6.3 Karius Personalized Medicine (PM) Solution Introduction
  • 11.6.4 Karius Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.6.5 Karius Recent Development
• 11.7 Astarte Medical
  • 11.7.1 Astarte Medical Company Details
  • 11.7.2 Astarte Medical Business Overview
  • 11.7.3 Astarte Medical Personalized Medicine (PM) Solution Introduction
  • 11.7.4 Astarte Medical Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.7.5 Astarte Medical Recent Development
• 11.8 Fabric Genomics, INC.
  • 11.8.1 Fabric Genomics, INC. Company Details
  • 11.8.2 Fabric Genomics, INC. Business Overview
  • 11.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Introduction
  • 11.8.4 Fabric Genomics, INC. Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.8.5 Fabric Genomics, INC. Recent Development
• 11.9 Orion Health
  • 11.9.1 Orion Health Company Details
  • 11.9.2 Orion Health Business Overview
  • 11.9.3 Orion Health Personalized Medicine (PM) Solution Introduction
  • 11.9.4 Orion Health Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.9.5 Orion Health Recent Development
• 11.10 2B Precise
  • 11.10.1 2B Precise Company Details
  • 11.10.2 2B Precise Business Overview
  • 11.10.3 2B Precise Personalized Medicine (PM) Solution Introduction
  • 11.10.4 2B Precise Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.10.5 2B Precise Recent Development
• 11.11 Fabric Genomics
  • 11.11.1 Fabric Genomics Company Details
  • 11.11.2 Fabric Genomics Business Overview
  • 11.11.3 Fabric Genomics Personalized Medicine (PM) Solution Introduction
  • 11.11.4 Fabric Genomics Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.11.5 Fabric Genomics Recent Development
• 11.12 Pfizer
  • 11.12.1 Pfizer Company Details
  • 11.12.2 Pfizer Business Overview
  • 11.12.3 Pfizer Personalized Medicine (PM) Solution Introduction
  • 11.12.4 Pfizer Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.12.5 Pfizer Recent Development
• 11.13 Gene 42
  • 11.13.1 Gene 42 Company Details
  • 11.13.2 Gene 42 Business Overview
  • 11.13.3 Gene 42 Personalized Medicine (PM) Solution Introduction
  • 11.13.4 Gene 42 Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.13.5 Gene 42 Recent Development
• 11.14 IBM Watson Health
  • 11.14.1 IBM Watson Health Company Details
  • 11.14.2 IBM Watson Health Business Overview
  • 11.14.3 IBM Watson Health Personalized Medicine (PM) Solution Introduction
  • 11.14.4 IBM Watson Health Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.14.5 IBM Watson Health Recent Development
• 11.15 Philips Healthcare
  • 11.15.1 Philips Healthcare Company Details
  • 11.15.2 Philips Healthcare Business Overview
  • 11.15.3 Philips Healthcare Personalized Medicine (PM) Solution Introduction
  • 11.15.4 Philips Healthcare Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.15.5 Philips Healthcare Recent Development
• 11.16 Medtronic
  • 11.16.1 Medtronic Company Details
  • 11.16.2 Medtronic Business Overview
  • 11.16.3 Medtronic Personalized Medicine (PM) Solution Introduction
  • 11.16.4 Medtronic Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.16.5 Medtronic Recent Development
• 11.17 Nanthealth
  • 11.17.1 Nanthealth Company Details
  • 11.17.2 Nanthealth Business Overview
  • 11.17.3 Nanthealth Personalized Medicine (PM) Solution Introduction
  • 11.17.4 Nanthealth Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.17.5 Nanthealth Recent Development
• 11.18 Navican
  • 11.18.1 Navican Company Details
  • 11.18.2 Navican Business Overview
  • 11.18.3 Navican Personalized Medicine (PM) Solution Introduction
  • 11.18.4 Navican Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.18.5 Navican Recent Development
• 11.18 N-of-One
  • 11.25.1 N-of-One Company Details
  • 11.25.2 N-of-One Business Overview
  • 11.25.3 N-of-One Personalized Medicine (PM) Solution Introduction
  • 11.25.4 N-of-One Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.25.5 N-of-One Recent Development
• 11.20 PierianDx
  • 11.20.1 PierianDx Company Details
  • 11.20.2 PierianDx Business Overview
  • 11.20.3 PierianDx Personalized Medicine (PM) Solution Introduction
  • 11.20.4 PierianDx Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.20.5 PierianDx Recent Development
• 11.21 Sunquest Information System
  • 11.21.1 Sunquest Information System Company Details
  • 11.21.2 Sunquest Information System Business Overview
  • 11.21.3 Sunquest Information System Personalized Medicine (PM) Solution Introduction
  • 11.21.4 Sunquest Information System Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.21.5 Sunquest Information System Recent Development
• 11.22 Tempus
  • 11.22.1 Tempus Company Details
  • 11.22.2 Tempus Business Overview
  • 11.22.3 Tempus Personalized Medicine (PM) Solution Introduction
  • 11.22.4 Tempus Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.22.5 Tempus Recent Development
• 11.23 Novartis
  • 11.23.1 Novartis Company Details
  • 11.23.2 Novartis Business Overview
  • 11.23.3 Novartis Personalized Medicine (PM) Solution Introduction
  • 11.23.4 Novartis Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.23.5 Novartis Recent Development
• 11.24 Translational Software
  • 11.24.1 Translational Software Company Details
  • 11.24.2 Translational Software Business Overview
  • 11.24.3 Translational Software Personalized Medicine (PM) Solution Introduction
  • 11.24.4 Translational Software Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.24.5 Translational Software Recent Development
• 11.25 Biocrates Life Sciences AG
  • 11.25.1 Biocrates Life Sciences AG Company Details
  • 11.25.2 Biocrates Life Sciences AG Business Overview
  • 11.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Introduction
  • 11.25.4 Biocrates Life Sciences AG Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.25.5 Biocrates Life Sciences AG Recent Development
• 11.26 Nanostring Technologies
  • 11.26.1 Nanostring Technologies Company Details
  • 11.26.2 Nanostring Technologies Business Overview
  • 11.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Introduction
  • 11.26.4 Nanostring Technologies Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.26.5 Nanostring Technologies Recent Development
• 11.27 Thermo Fisher Scientific
  • 11.27.1 Thermo Fisher Scientific Company Details
  • 11.27.2 Thermo Fisher Scientific Business Overview
  • 11.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Introduction
  • 11.27.4 Thermo Fisher Scientific Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.27.5 Thermo Fisher Scientific Recent Development
• 11.28 Quest Diagnostics Incorporated
  • 11.28.1 Quest Diagnostics Incorporated Company Details
  • 11.28.2 Quest Diagnostics Incorporated Business Overview
  • 11.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Introduction
  • 11.28.4 Quest Diagnostics Incorporated Revenue in Personalized Medicine (PM) Solution Business (2016-2021)
  • 11.28.5 Quest Diagnostics Incorporated Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer